Invivogen
Menu

THP1-Dual™ KO-MAVS Cells

Product Unit size Cat. code Docs. Qty. Price

THP1-Dual™ KO-MAVS Cells

Human THP-1 Monocytes - MAVS knockout NF-κB-SEAP and IRF-Lucia Reporter Cells

Show product

3-7 x 10e6 cells

thpd-komavs
+-
$1,752

KO-MAVS dual reporter monocytes for RLR pathway studies

Reporter systems in THP1-Dual™-derived cells
Reporter systems in THP1-Dual™-derived cells

 

InvivoGen offers a new series of THP1-Dual™ cell lines,  derived from the human THP-1 monocytic cell line, and specifically designed for assessing the role of RIG-I, MDA5, and MAVS in the cytosolic RNA sensing pathways.

THP1-Dual™ KO-MAVS cells express two inducible reporter genes, allowing the concomitant study of the IRF and NF-κB pathways, by monitoring the Lucia luciferase and SEAP (secreted embryonic alkaline phosphatase) activities, respectively. In addition, these cells feature stable knockout of the MAVS (Mitochondrial antiviral-signaling protein) gene.

 

RIG-I and MDA5 are two distinct sensors of viral double-stranded RNA (dsRNA), a replication intermediate for RNA viruses [1-3]. Upon recognition of dsRNA, RIG-I and MDA5 are recruited by the MAVS adaptor to the outer membrane of the mitochondria leading to the activation of several transcription factors, including interferon regulatory factors (IRFs) and NF-κB [3].

More details More details

 

KEY FEATURES:

  • Verified knockout of MAVS genes (PCR, DNA sequencing, Western blot, and functional assays)
  • Functionally validated with a selection of PRR ligands and cytokines
  • Readily assessable Lucia luciferase and SEAP reporter activities
  • The stability for 20 passages, following thawing, has been verified
  • Guaranteed mycoplasma-free

APPLICATIONS:

  • Defining the role of MAVS in cytosolic RNA sensing pathways
  • Highlighting possible overlap between RIG-I, MDA5, MAVS, and STING signaling functions
  • Developing novel specific inhibitors of the RLR signaling pathway

 

References

1. Gebhardt A. et al., 2017. Discrimination of Self and Non-Self Ribonucleic Acids. Journal of Interferon & Cytokine Research 37: 184-97.
2. Pichlmair A. et al., 2006. RIG-I mediated antiviral responses to single-stranded RNA bearing 5’-phosphates. Science 314:997-1001.
3. Kawai T. et al., 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 6(10):981-988.

Figures

Validation of MAVS knockout
Validation of MAVS knockout

Validation of MAVS KO.
(A) The targeted MAVS region in THP1-Dual™ (WT; blue arrow) parental cells and THP1-Dual™ KO-MAVS (KO; red arrow) cells was amplified by PCR. THP1-Dual™ KO-MAVS cells feature a frameshift deletion, causing an early stop codon and inactivation of MAVS. (B) Lysates from THP1-Dual™ (WT) and THP1-Dual™ KO-MAVS (KO) cells were analyzed using an anti-human MAVS antibody (green arrow), followed by a HRP-conjugated anti-rabbit secondary antibody (WES assay). As expected, a band was detected at ~80 Da in the WT cells only.


IRF responses in THP1-Dual-derived cells.
THP1-Dual
(WT) and THP1-Dual KO-MAVS cells were incubated with 1 ng/ml human TNF-α (hTNF-α), or 104 U/ml human IFN-β (hIFN-β), 300 ng/ml 3p-hpRNA/Lyovec, 1 μg/ml Poly(I:C) HMW/LTX, 1 μg/ml VACV-70/Lyovec, 3 μg/ml 2’3’-cGAMP, 3 ng/ml Pam3CSK4, or 1 μg/ml R848. After overnight incubation, the IRF response was assessed by measuring Lucia luciferase activity in the supernatant using QUANTI-Luc. Data are shown as a fold change (mean ± SEM) over non-induced cells.

Functional validation of MAVS knockout (NF-κB response)
Functional validation of MAVS knockout (NF-κB response)

NF-κB responses in THP1-Dual™-derived cells.
THP1-Dual™ (WT) and THP1-Dual™ KO-MAVS cells were incubated with 1 ng/ml human TNF-α (hTNF-α), or 104 U/ml human IFN-β (hIFN-β), 300 ng/ml 3p-hpRNA/Lyovec, 1 μg/ml Poly(I:C) HMW/LTX, 1 μg/ml VACV-70/Lyovec, 3 μg/ml 2’3’-cGAMP, 3 ng/ml Pam3CSK4, or 1 μg/ml R848. After overnight incubation, the NF-κB activity was assessed by measuring the SEAP activity in the supernatant using QUANTI-Blue™ Solution. Data are shown as optical density (OD) at 630 nm (mean ± SEM).

Back to the top

Specifications

Growth medium: RPMI 1640, 2 mM L-glutamine, 25 mM HEPES, 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml Normocin™

Antibiotic resistance: Blasticidin and Zeocin®

Quality Control:

  • Biallelic MAVS knockout has been verified by PCR, DNA sequencing, and functional assays.
  • The stability for 20 passages, following thawing, has been verified. 
  • These cells are guaranteed mycoplasma-free. 

 

InvivoGen's products are covered by a Limited Use License (See Terms and Conditions).

Back to the top

Contents

  • 3-7 x 106 cells in a cryovial or shipping flask
  • 1 ml of Blasticidin (10 mg/ml)
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Normocin™ (50 mg/ml). Normocin™ is a formulation of three antibiotics active against mycoplasmas, bacteria, and fungi.
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
  • 1 tube of QUANTI-Luc™ 4 Reagent, a Lucia luciferase detection reagent (sufficient to prepare 25 ml)

Dry ice shipping Shipped on dry ice (Europe, USA, Canada, and some areas in Asia)

Back to the top

Details

MAVS (mitochondrial antiviral-signaling protein, also known as IPS‑1, CARDIF, VISA)

MAVS is an adaptor protein that plays a critical role in the immune response to viral infection. The innate immune system senses intracellular double-stranded RNA (dsRNA), a replication intermediate for RNA viruses, through two RNA helicases: retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-association gene 5 (MDA5). Upon recognition of dsRNA, RIG-I and MDA5 are recruited by MAVS to the outer membrane of the mitochondria leading to the activation of several transcription factors including interferon-regulatory factor 3 (IRF3), IRF7, and NF-κB. IRFs and NF-κB regulate the expression of type I interferons (IFNs) and pro-inflammatory cytokines, respectively [1, 2].

RIG-I (retinoic-acid-inducible protein 1, also known as Ddx58)

RIG-I is a cytoplasmic RNA helicase that is critical for host antiviral responses. It senses double-stranded RNA (dsRNA), a replication intermediate for RNA viruses, leading to the production of type I interferons (IFNs) [1]. RIG-I binds specifically to short dsRNAs that have blunt ends and a 5’-triphosphate (5’-ppp) moiety, facilitating discrimination between host and viral dsRNA [3].

MDA5 (melanoma-differentiation-associated gene 5, also known as Ifih1 or Helicard)

MDA5 is a cytoplasmic RNA helicase that plays an important role in antiviral response. It senses long double-stranded RNA (dsRNA), a replication intermediate for RNA viruses, leading to the production of type I interferons (IFNs) [1]. MDA-5 and the related RNA helicase RIG-I recognize a complementary set of cytosolic viral dsRNA. Transfected Poly(I:C), a synthetic analog of viral dsRNA, is recognized by both MDA-5 and RIG-I.

 

1. Gebhardt A. et al., 2017. Discrimination of Self and Non-Self Ribonucleic Acids. Journal of Interferon & Cytokine Research 37: 184-97.
2. Kawai T. et al., 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 6(10):981-988.
3. Pichlmair A. et al., 2006. RIG-I mediated antiviral responses to single-stranded RNA bearing 5’-phosphates. Science 314:997-1001.

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top

Notification:  These products are for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.

Customer Service
& Technical Support
Shopping cart is empty